Risperidone ODT 2mg Tablets
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your medication with or without food, as directed. Continue taking it as prescribed by your doctor or healthcare provider, even if you're feeling well.
When taking your medication, make sure to:
Remove it from the blister pack only when you're ready to take it
Take it immediately after opening the blister pack
Do not store the removed medication for future use
Use dry hands to remove the tablet from the foil
Place the tablet on your tongue and let it dissolve; water is not necessary
Do not swallow the tablet whole, chew, break, or crush it
Storing and Disposing of Your Medication
To store your medication properly:
Keep it at room temperature, protected from light
Store it in a dry place, avoiding bathrooms
Keep all medications in a safe location, out of reach of children and pets
When disposing of your medication:
Throw away any unused or expired medication
Do not flush it down the toilet or pour it down the drain unless instructed to do so
Check with your pharmacist for guidance on proper disposal
* Consider participating in local drug take-back programs
Missing a Dose
If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at the same time or take extra doses.
Lifestyle & Tips
- Take exactly as prescribed, do not stop suddenly without consulting your doctor.
- Do not push the ODT tablet through the foil; peel back the foil and gently remove the tablet.
- Place the tablet on your tongue immediately after opening the blister pack. It will dissolve quickly and can be swallowed with or without water.
- Avoid alcohol and other CNS depressants as they can increase drowsiness.
- Be aware of potential for dizziness or lightheadedness, especially when standing up quickly (orthostatic hypotension).
- Monitor for weight gain and discuss healthy diet and exercise with your doctor.
- Report any unusual or uncontrollable movements (especially of the face, tongue, or limbs) to your doctor immediately.
- Stay hydrated, especially in hot weather, to prevent overheating.
- Regularly attend follow-up appointments and blood tests as advised by your doctor.
Available Forms & Alternatives
Available Strengths:
- Risperidone ODT 0.25mg Tablets
- Risperidone 1mg/ml Oral Soln 30ml
- Risperidone ODT 2mg Tablets
- Risperidone ODT 0.5mg Tablets
- Risperidone 0.5mg Tablets
- Risperidone 3mg Tablets
- Risperidone 4mg ODT Tablets
- Risperidone 1mg Tablets
- Risperidone 0.25mg Tablets
- Risperidone 2mg Tablets
- Risperidone 4mg Tablets
- Risperidone ODT 3mg Tablets
- Risperidone ODT 1mg Tablets
- Risperidone ER 25mg Inj Susp Kit
- Risperidone ER 50mg Inj Susp Kit
- Risperidone ER 37.5mg Inj Susp Kit
- Risperidone ER 12.5mg Inj, 1 Vial
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:
Signs of an allergic reaction, such as:
+ Rash or hives
+ Itching or red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing or tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness or swelling of the mouth, face, lips, tongue, or throat
Signs of high blood sugar, including:
+ Confusion or feeling sleepy
+ Unusual thirst or hunger
+ Frequent urination or flushing
+ Rapid breathing or breath that smells like fruit
Severe dizziness or fainting
Changes in behavior or mood
Shakiness, difficulty moving, or stiffness
Urination problems (inability to pass urine or changes in urine output)
Difficulty swallowing or speaking
Trouble focusing
Seizures
Changes in vision
Shortness of breath
Drooling
Feeling extremely hot or cold
Hormonal changes, such as:
+ Enlarged breasts or nipple discharge
+ Erectile dysfunction or menstrual changes
+ Decreased sex drive or ejaculation problems
Prolonged or painful erections (lasting more than 4 hours): seek medical attention immediately to prevent long-term sexual dysfunction
Serious but Rare Side Effects
Neuroleptic malignant syndrome (NMS): a potentially life-threatening condition. Seek medical help right away if you experience:
+ Fever
+ Muscle cramps or stiffness
+ Dizziness
+ Severe headache
+ Confusion or changes in thinking
+ Rapid or irregular heartbeat
+ Excessive sweating
Low white blood cell count: increases the risk of infection. Inform your doctor if you have a history of low white blood cell count. Seek medical attention if you experience:
+ Fever
+ Chills
+ Sore throat
Tardive dyskinesia: a severe muscle disorder that may be irreversible. Seek medical help if you experience:
+ Uncontrolled body movements
+ Tongue, face, mouth, or jaw problems (e.g., tongue sticking out, puffing cheeks, mouth puckering, or chewing)
Other Possible Side Effects
While many people may not experience side effects or only have mild ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects, contact your doctor or seek medical attention if they bother you or persist:
Weight gain
Restlessness
Dizziness, drowsiness, tiredness, or weakness
Anxiety
Constipation, diarrhea, stomach pain, upset stomach, or vomiting
Heartburn
Dry mouth
Changes in appetite
Common cold symptoms
Headache
Sleep disturbances
Back, muscle, arm, or leg pain
Reporting Side Effects
If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Fever, muscle stiffness, confusion, sweating, or fast/irregular heartbeat (signs of Neuroleptic Malignant Syndrome)
- Uncontrolled movements of your face, tongue, or other body parts (signs of Tardive Dyskinesia)
- Dizziness, lightheadedness, or fainting, especially when standing up
- Difficulty swallowing or breathing
- Increased thirst, increased urination, increased hunger, or unexplained weight loss (signs of high blood sugar)
- Breast enlargement, nipple discharge, missed periods, or sexual problems (signs of high prolactin levels)
- Sudden weakness or numbness on one side of the body, slurred speech, or vision changes (signs of a stroke, especially in elderly with dementia)
- Severe skin rash or allergic reaction
- Thoughts of self-harm or worsening depression
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, any of its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
All medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This information will help your doctor and pharmacist identify potential interactions between this medication and other substances you are taking.
* Any health problems you have, as this medication may interact with certain conditions.
To ensure your safety, it is crucial to verify that it is safe to take this medication with all your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
Precautions & Cautions
When starting this medication, be cautious when driving or performing tasks that require your full attention, as it may affect your alertness. To minimize the risk of dizziness or fainting, get up slowly from a sitting or lying position, and be careful when climbing stairs.
You may not experience the full effects of this medication for several weeks. Additionally, be aware that medications like this one have been associated with increased risks of high blood sugar, diabetes, high cholesterol, and weight gain, which may contribute to heart and brain blood vessel disease.
As directed by your doctor, monitor your blood sugar levels regularly. Also, follow your doctor's instructions for having blood work checked, and discuss any concerns or questions you may have with your doctor.
Avoid consuming alcohol while taking this medication. Before using marijuana, cannabis, or any prescription or over-the-counter drugs that may cause drowsiness, consult with your doctor.
In hot weather or during physical activity, be mindful of your fluid intake to prevent dehydration. Drink plenty of fluids to stay hydrated.
This medication may cause dizziness, drowsiness, and impaired balance, which can increase the risk of falls and related injuries, such as fractures.
If you have phenylketonuria (PKU), consult your doctor, as some products contain phenylalanine.
Older adults with dementia who take medications like this one have a higher risk of experiencing strokes, which can be fatal. Note that this medication is not approved for treating dementia-related mental health issues.
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.
This medication may affect fertility, but this effect is reversible once the medication is discontinued. If you have concerns, discuss them with your doctor.
Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. It is crucial to discuss the potential benefits and risks of this medication for both you and your baby. Taking this medication during the third trimester of pregnancy may cause side effects or withdrawal symptoms in the newborn.
Overdose Information
Overdose Symptoms:
- Severe drowsiness or sedation
- Fast or irregular heartbeat
- Low blood pressure (dizziness, fainting)
- Extrapyramidal symptoms (severe muscle stiffness, tremor, uncontrolled movements)
- Seizures
- Coma
What to Do:
Seek immediate medical attention. Call 911 or your local emergency number. In the US, you can also call a poison control center at 1-800-222-1222.
Drug Interactions
Major Interactions
- CNS depressants (e.g., opioids, benzodiazepines, alcohol): Increased sedation and CNS depression.
- Drugs that prolong QT interval (e.g., Class IA and III antiarrhythmics, moxifloxacin, thioridazine): Increased risk of arrhythmias.
- Dopamine agonists (e.g., levodopa, bromocriptine): Antagonism of effects.
- CYP2D6 inhibitors (e.g., fluoxetine, paroxetine, quinidine): Can increase risperidone plasma levels and active moiety.
Moderate Interactions
- CYP3A4 inducers (e.g., carbamazepine, phenytoin, rifampin): Can decrease risperidone and active moiety plasma levels.
- CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): Can increase risperidone plasma levels.
- Antihypertensives: Enhanced hypotensive effects.
- Diuretics (especially in elderly with dementia): Increased risk of mortality and cerebrovascular events.
- Cimetidine, ranitidine: May increase risperidone bioavailability (minor effect).
Minor Interactions
- Lithium: No significant pharmacokinetic interaction, but monitor for additive CNS effects.
- Valproate: No significant pharmacokinetic interaction, but monitor for additive CNS effects.
Monitoring
Baseline Monitoring
Rationale: To assess for blood dyscrasias (e.g., leukopenia, neutropenia) which are rare but serious side effects.
Timing: Prior to initiation
Rationale: To assess for electrolyte imbalances that could predispose to cardiac arrhythmias, especially with QTc prolongation risk.
Timing: Prior to initiation
Rationale: To assess baseline hepatic function, especially important for a hepatically metabolized drug.
Timing: Prior to initiation
Rationale: To assess baseline renal function, as dose adjustments are needed in renal impairment.
Timing: Prior to initiation
Rationale: To assess for baseline hyperglycemia, as atypical antipsychotics can cause metabolic changes.
Timing: Prior to initiation
Rationale: To assess for baseline dyslipidemia, as atypical antipsychotics can cause metabolic changes.
Timing: Prior to initiation
Rationale: To establish baseline for monitoring weight gain and metabolic syndrome risk.
Timing: Prior to initiation
Rationale: To assess for baseline orthostatic hypotension risk and cardiovascular status.
Timing: Prior to initiation
Rationale: To assess for baseline QTc interval and other cardiac abnormalities, especially in patients with cardiac risk factors.
Timing: Prior to initiation (consider for high-risk patients)
Rationale: To assess baseline, as risperidone can cause hyperprolactinemia.
Timing: Prior to initiation (consider for patients with symptoms or risk factors)
Rationale: To establish baseline for monitoring extrapyramidal symptoms (EPS) and tardive dyskinesia (TD).
Timing: Prior to initiation
Routine Monitoring
Frequency: Monthly for first few months, then quarterly
Target: Maintain stable weight; minimize increase in waist circumference
Action Threshold: Significant weight gain (>5% baseline) or rapid increase in waist circumference warrants intervention (diet, exercise, consider alternative).
Frequency: At 3 months, then annually
Target: <100 mg/dL
Action Threshold: Fasting glucose âĨ100 mg/dL (prediabetes) or âĨ126 mg/dL (diabetes) warrants further evaluation and management.
Frequency: At 3 months, then annually
Target: LDL <100 mg/dL, HDL >40 mg/dL (men), >50 mg/dL (women), Triglycerides <150 mg/dL
Action Threshold: Significant dyslipidemia warrants further evaluation and management.
Frequency: At each visit, especially during dose titration
Target: Within normal limits, no significant orthostatic changes
Action Threshold: Persistent orthostatic hypotension (drop of âĨ20 mmHg systolic or âĨ10 mmHg diastolic) or significant hypertension warrants intervention.
Frequency: Quarterly to annually
Target: No new or worsening EPS/TD
Action Threshold: Emergence or worsening of EPS/TD warrants dose adjustment, anticholinergic medication, or consideration of alternative antipsychotic.
Frequency: Annually or if symptoms of hyperprolactinemia (e.g., amenorrhea, galactorrhea, gynecomastia, sexual dysfunction) develop.
Target: Within normal limits
Action Threshold: Symptomatic hyperprolactinemia warrants evaluation and potential intervention (dose reduction, alternative medication, or specific treatment).
Frequency: Periodically, especially if cardiac risk factors, electrolyte abnormalities, or symptoms of arrhythmia develop.
Target: QTc <450 ms (men), <470 ms (women)
Action Threshold: QTc prolongation >500 ms or increase of >60 ms from baseline warrants immediate evaluation and potential discontinuation.
Symptom Monitoring
- Sedation/Somnolence
- Dizziness/Orthostatic Hypotension
- Extrapyramidal Symptoms (tremor, rigidity, akathisia, dystonia)
- Tardive Dyskinesia (involuntary movements, especially of face and tongue)
- Weight gain
- Changes in appetite or thirst
- Symptoms of hyperglycemia (increased thirst, urination, hunger)
- Symptoms of hyperprolactinemia (galactorrhea, amenorrhea, gynecomastia, sexual dysfunction)
- Changes in mood or behavior (e.g., agitation, aggression, suicidal ideation)
- Signs of Neuroleptic Malignant Syndrome (fever, muscle rigidity, altered mental status, autonomic instability)
- Signs of cerebrovascular events (sudden weakness, numbness, speech changes, vision changes) in elderly dementia patients
Special Patient Groups
Pregnancy
Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Neonates exposed to antipsychotic drugs during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery.
Trimester-Specific Risks:
Lactation
Risperidone and its active metabolite are excreted in human breast milk. Weigh the benefits of breastfeeding against the potential risks to the infant. Monitor breastfed infants for sedation, poor feeding, and developmental milestones.
Pediatric Use
Approved for irritability associated with autistic disorder (5-16 years), schizophrenia (13-17 years), and bipolar mania (10-17 years). Dosing is weight-based and titrated slowly. Monitor closely for weight gain, metabolic changes, and EPS.
Geriatric Use
Elderly patients, especially those with dementia-related psychosis, are at increased risk of mortality and cerebrovascular adverse events (e.g., stroke, transient ischemic attack). Risperidone is not approved for dementia-related psychosis. Start with lower doses and titrate slowly due to potential for increased sensitivity to side effects (e.g., orthostatic hypotension, sedation, EPS).
Clinical Information
Clinical Pearls
- Risperidone ODT should be handled with dry hands and placed on the tongue immediately after opening the blister pack. It dissolves rapidly and can be swallowed with or without liquid.
- Due to the risk of orthostatic hypotension, especially at initiation and during dose escalation, advise patients to rise slowly from a sitting or lying position.
- Monitor for hyperprolactinemia, which can lead to symptoms like galactorrhea, amenorrhea, gynecomastia, and sexual dysfunction. Consider prolactin levels if symptoms arise.
- Be vigilant for metabolic side effects including weight gain, hyperglycemia, and dyslipidemia. Regular monitoring of these parameters is crucial.
- The active metabolite, 9-hydroxyrisperidone (paliperidone), contributes significantly to the drug's effects and has a much longer half-life, influencing dosing frequency and steady-state attainment.
- Patients who are CYP2D6 poor metabolizers may have higher risperidone levels and lower 9-hydroxyrisperidone levels, but the total active moiety generally remains similar, though individual responses may vary.
Alternative Therapies
- Other atypical antipsychotics (e.g., Olanzapine, Quetiapine, Aripiprazole, Ziprasidone, Lurasidone, Cariprazine, Brexpiprazole)
- Typical antipsychotics (e.g., Haloperidol, Chlorpromazine) - generally less preferred due to higher EPS risk
- Mood stabilizers (e.g., Lithium, Valproate, Carbamazepine) for bipolar disorder
- SSRIs/SNRIs for co-occurring anxiety/depression (if appropriate and not primary indication)